PIL - Preblacon XL 4mg Prolonged-release Capsules, hard: Change history
View Patient Information Leaflet (PIL - Preblacon XL 4mg Prolonged-release Capsules, hard)
Last updated on this site: 07 Nov 2024
This notification was submitted to amend the packaging
components without the need to amend the SmPC. Changes are as follows;
- To create a replacement PIL on the new profile, the profile size remains the same 170 x 250, but the gap between the text and the edge of the keyline is now 12mm instead of 10mm. The position of the pharma code placement has also moved.
- Added the word ‘as’ into the introduction. This now reads ‘within the leaflet it will be referred to as Preblacon capsules’
-The PIL revision date has been revised to August 2024
Last updated on this site: 07 Nov 2024
This notification was submitted to amend the packaging
components without the need to amend the SmPC. Changes are as follows;
- To create a replacement PIL on the new profile, the profile size remains the same 170 x 250, but the gap between the text and the edge of the keyline is now 12mm instead of 10mm. The position of the pharma code placement has also moved.
- Added the word ‘as’ into the introduction. This now reads ‘within the leaflet it will be referred to as Preblacon capsules’
-The PIL revision date has been revised to August 2024
-
Changes: (Updated: 07 Nov 2024)
This notification was submitted to amend the packaging
components without the need to amend the SmPC. Changes are as follows;
- To create a replacement PIL on the new profile, the profile size remains the same 170 x 250, but the gap between the text and the edge of the keyline is now 12mm instead of 10mm. The position of the pharma code placement has also moved.
- Added the word ‘as’ into the introduction. This now reads ‘within the leaflet it will be referred to as Preblacon capsules’
-The PIL revision date has been revised to August 2024
-
Changes: (Updated: 22 Sep 2022)
Initial upload